TY  - GEN
AU  - Miller,David M
AU  - Flaherty,Keith T
AU  - Tsao,Hensin
TI  - Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma
SN  - 1085-5629
PY  - 2014///1020
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - CTLA-4 Antigen
KW  - antagonists & inhibitors
KW  - Humans
KW  - Immunologic Factors
KW  - Immunotherapy
KW  - Interferon-alpha
KW  - Interleukin-2
KW  - Melanoma
KW  - genetics
KW  - Mitogen-Activated Protein Kinase Kinases
KW  - Molecular Targeted Therapy
KW  - Mutation
KW  - Programmed Cell Death 1 Receptor
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins B-raf
KW  - Proto-Oncogene Proteins c-kit
KW  - Skin Neoplasms
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.12788/j.sder.0081
ER  -